Off-the-shelf consumer wearables have shown a benefit when used to monitor the response to treatment in patients with atrial fibrillation (AF) and heart failure (HF).
Health systems around the world are dealing with cancelled appointments and other disruptions to services in the wake of the global IT outage that hit on Friday, which is now thought to be
The FDA has said it will create a rare disease innovation hub to help speed the development of new treatments and build connections between developers and the rare disease community.
Boehringer Ingelheim has joined forces with digital health firm Brainomix on a project to improve the care of people with fibrosing lung diseases in the US.
The hot list of policies for the new Labour government in the UK, laid out in the King's Speech today, focused mainly on economic growth but included several announcements related to health
Clinical trials are strictly regulated to ensure patient safety, but the current framework in the UK is stifling early-phase clinical research, making it harder to advance novel therapies t